Abstract
Chronic inflammatory conditions may augment tumor growth, but in this issue of Blood, Kryczek and colleagues1 find that endogenous IL-17 may not be one of the contributing factors.
Cite
CITATION STYLE
APA
Muranski, P., & Restifo, N. P. (2009). Does IL-17 promote tumor growth? Blood. American Society of Hematology. https://doi.org/10.1182/blood-2009-04-215541
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free